What's Happening?
Multiply Labs, a robotics company based in San Francisco, has expanded its collaboration with Thermo Fisher Scientific to advance automation in cell therapy manufacturing. The partnership will integrate Thermo Fisher's Gibco CTS DynaCellect Magnetic Separation System with Multiply Labs' robotic platforms. This system is designed for automated isolation, activation, and bead removal in cell therapy development. The collaboration aims to reduce manual intervention and improve process consistency, enhancing the production of cell therapies. This builds on previous collaborations focused on automating cell expansion and separation processes.
Why It's Important?
The expansion of this collaboration is significant for the biotechnology and healthcare sectors, as it promises to streamline cell therapy manufacturing. By automating complex biomanufacturing workflows, the partnership could lead to more efficient and cost-effective production processes. This is crucial for meeting the growing demand for cell therapies, which are increasingly important in treating various diseases. The collaboration also highlights the role of automation in reducing human error and accelerating the delivery of therapies to patients, potentially transforming the landscape of medical treatment.
